Approaches to treatment of type 2 diabetes

被引：13

作者：

Bloomgarden, Zachary T. ^{[1
]}

机构：

[1] Mt Sinai Sch Med, Div Endocrinol, New York, NY USA

来源：

DIABETES CARE | 2008年 / 31卷 / 08期

关键词：

D O I：

10.2337/dc08-zb08

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1697 / 1703

页数：7

共 50 条

[1] Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes [J].

Aschner, Pablo ;

Kipnes, Mark S. ;

Lunceford, Jared K. ;

Sanchez, Matilde ;

Mickel, Carolyn ;

Williams-Herman, Debora E. .

DIABETES CARE, 2006, 29 (12) :2632-2637

[2] Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach [J].

Bays, H ;

Mandarino, L ;

DeFronzo, RA .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) :463-478

[3] A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis [J].

Belfort, Renata ;

Harrison, Stephen A. ;

Brown, Kenneth ;

Darland, Celia ;

Finch, Joan ;

Hardies, Jean ;

Balas, Bogdan ;

Gastaldelli, Amalia ;

Tio, Fermin ;

Pulcini, Joseph ;

Berria, Rachele ;

Ma, Jennie Z. ;

Dwivedi, Sunil ;

Havranek, Russell ;

Fincke, Chris ;

DeFronzo, Ralph ;

Bannayan, George A. ;

Schenker, Steven ;

Cusi, Kenneth .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) :2297-2307

[4] The proposed terminology 'A1c-derived average glucose' is inherently imprecise and should not be adopted [J].

Bloomgarden, Z. T. ;

Inzucchi, S. E. ;

Karnieli, E. ;

Le Roith, D. .

DIABETOLOGIA, 2008, 51 (07) :1111-1114

[5] Lower baseline glycemia reduces apparent oral agent glucose-lowering efficacy - A meta-regression analysis [J].

Bloomgarden, Zachary T. ;

Dodis, Regina ;

Viscoli, Catherine M. ;

Holmboe, Eric S. ;

Inzucchi, Silvio E. .

DIABETES CARE, 2006, 29 (09) :2137-2139

[6] Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes Mellitus [J].

Bolen, Shari ;

Feldman, Leonard ;

Vassy, Jason ;

Wilson, Lisa ;

Yeh, Hsin-Chieh ;

Marinopoulos, Spyriclon ;

Wiley, Crystal ;

Selvin, Elizabeth ;

Wilson, Renee ;

Bass, Eric B. ;

Brancati, Frederick L. .

ANNALS OF INTERNAL MEDICINE, 2007, 147 (06) :386-399

[7] The burden of treatment failure in type 2 diabetes [J].

Brown, JB ;

Nichols, GA ;

Perry, A .

DIABETES CARE, 2004, 27 (07) :1535-1540

[8] Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women [J].

Buchanan, TA ;

Xiang, AH ;

Peters, RK ;

Kjos, SL ;

Marroquin, A ;

Goico, J ;

Ochoa, C ;

Tan, S ;

Berkowitz, K ;

Hodis, HN ;

Azen, SP .

DIABETES, 2002, 51 (09) :2796-2803

[9] Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone [J].

Charbonnel, Bernard ;

Karasik, Avraham ;

Liu, Ji ;

Wu, Mei ;

Meininger, Gary .

DIABETES CARE, 2006, 29 (12) :2638-2643

[10] Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death [J].

Diamond, George A. ;

Bax, Leon ;

Kaul, Sanjay .

ANNALS OF INTERNAL MEDICINE, 2007, 147 (08) :578-581

← 1 2 3 4 5 →